University Hospital of Geneva
Welcome,         Profile    Billing    Logout  
 55 Trials 
22 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gottlieb, Jens
BOSTON-2, NCT03656926 / 2018-003205-25: Efficacy + Safety of Liposome Cyclosporine a to Treat Bronchiolitis Obliterans Post Single Lung Transplant

Completed
3
220
Europe, US, RoW
Liposomal Cyclosporine A, L-CsA, Standard of Care, SoC
Zambon SpA, BREATH Therapeutics Inc.
Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection, Lung Transplant; Complications, Lung Transplant Failure and Rejection, Chronic Lung Allograft Dysfunction
03/24
03/24
BOSTON-1, NCT03657342 / 2018-003204-39: Efficacy + Safety of Liposome Cyclosporine a to Treat Bronchiolitis Obliterans Post Single Lung Transplant

Completed
3
220
Europe, US, RoW
Liposomal Cyclosporine A, L-CsA, standard of care, SoC
Zambon SpA, BREATH Therapeutics Inc.
Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection, Lung Transplant; Complications, Lung Transplant Failure and Rejection, Chronic Lung Allograft Dysfunction
04/24
04/24
TAK-620-5010, NCT06615921: A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection

Recruiting
N/A
150
Europe, RoW
No Intervention
Takeda
Cytomegalovirus (CMV)
04/25
04/25
Benhamou, Pierre-Yves
Close2target, NCT05369871: Evaluation of a Closed-loop System for the Treatment of Type 2 Diabetes at Home (DT2_2)

Completed
N/A
20
Europe
Closed-loop system, Open-loop system
Diabeloop, Icadom, AGIR à Dom, University Hospital, Grenoble, Centre Hospitalier Annecy Genevois, Centre Hospitalier Metropole Savoie
Diabetes Mellitus Type 2 - Insulin-Treated
05/23
07/23
BETTER, NCT05628532: DBLG1 System With TERUMO MEDISAFE WITH Insulin Pump Trial

Completed
N/A
90
Europe
Use of the DBLG1 system
Diabeloop, Icadom
Diabetes Mellitus, Type 1
02/24
04/24
SERENIT2, NCT05733962: Evaluation of the Efficacy and Safety of DBL-4pen Mobile Application in Patients With Type 2 Diabetes

Not yet recruiting
N/A
40
Europe
Use of the device DBL-4pen
Diabeloop, Icadom
Diabetes Mellitus, Type 2
12/24
01/25
SP12, NCT04749693: Observational Study of the Use of DBLG1 System in Real Life

Recruiting
N/A
348
Europe
DBLG1 System
Diabeloop
Type1diabetes
07/25
01/26
Rimensberger, Peter
NCT06114992: Servo-n HFOV Study: Safety and Performance in Neonates and Infants

Recruiting
N/A
75
Europe
Servo-n HFOV modes
Maquet Critical Care AB, NAMSA, Paediatric and Neonatal Mechanical Ventilation (PNV) Consulting
Elective HFOV for Respiratory Failure in Neonates/Infants, Rescue HFOV in Neonates and/Infants With Refractory Respiratory Failure Under Conventional Therapy
11/26
12/26
Burri, Haran
NCT04496518: Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)

Active, not recruiting
N/A
2200
Europe, US
Intrinsic Antitachycardia Pacing (iATP) Therapy
Medtronic
Ventricular Tachycardia
01/25
01/27
NCT04489225: Personalized Therapy Study - HFRS (TriageHF) Post Approval Study

Active, not recruiting
N/A
2200
Europe, US
Observational
Medtronic
Heart Failure
01/25
01/27
LEAP-pilot, NCT04595487: LVSP vs RVP in Patients With AV Conduction Disorders

Recruiting
N/A
470
Europe, RoW
Left ventricular septal pacing, Right ventricular pacing
Maastricht University, ZonMw: The Netherlands Organisation for Health Research and Development, Medtronic
Cardiac Pacing, Pacing-Induced Cardiomyopathy, Conduction System Pacing, Left Ventricular Septal Pacing, Atrioventricular Block
05/25
05/25
ASQ, NCT04024943: Personalized Therapy Study - Attain Stability Quad Post-Approval Study

Active, not recruiting
N/A
1092
Europe, US
Quadripolar LV Lead, Medtronic CRT-P, Medtronic CRT-D
Medtronic
Heart Failure
01/27
04/27
Righini, Marc
SAFE-SSPE, NCT04263038: Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

Recruiting
4
276
Europe, Canada
Rivaroxaban, Placebo
Drahomir Aujesky, University of Bern, Schweizerischer Nationalfonds, Leiden University Medical Center, The Ottawa Hospital, Bayer
Pulmonary Embolism, Embolism, Embolism and Thrombosis, Lung Diseases, Cardiovascular Diseases, Respiratory Tract Diseases, Venous Thromboembolism, Anticoagulant-induced Bleeding, Bleeding
05/26
05/26
PEITHO-3, NCT04430569 / 2018-000816-96: Pulmonary Embolism International THrOmbolysis Study-3

Recruiting
3
650
Europe, Canada, RoW
Alteplase, Placebo
Assistance Publique - Hôpitaux de Paris, Johannes Gutenberg University Mainz, Life Sciences Research Partners (D Collen Research Foundation), Canadian Institutes of Health Research (CIHR), Instituto de Salud Carlos III, International Network of VENous Thromboembolism Clinical Research Networks, Boehringer Ingelheim
Pulmonary Embolism
09/25
08/27
Sun, Pamela
NICO, NCT05517122: Effect of Oral NAD+ Precursors Administration on Blood NAD+ Concentration in Healthy Adults

Active, not recruiting
N/A
68
Europe
Nicotinamide (NAM), Nicotinamide Riboside (NR), Nicotinamide Mono Nucleotide (NMN), Microcrystalline cellulose
Société des Produits Nestlé (SPN)
Healthy
12/22
12/23
NCT05555004: Evaluation of Probiotic (L.Reuteri) Survival in Presence of Prebiotic Galacto-oligosaccharides

Terminated
N/A
25
Europe
TEST1, TEST 2
Société des Produits Nestlé (SPN)
Healthy
04/23
04/23
NCT05923593: Tolerance and Safety of an Oral Nutritional Supplement (Adolescent Cohort)

Completed
N/A
12
Europe
MAG oil oral nutritional supplement (ONS)
Société des Produits Nestlé (SPN)
Healthy Volunteers
06/23
08/23
NCT05058157: Ketone Plasma Kinetics After Oral Intake of Different Ketogenic Formulae

Active, not recruiting
N/A
20
Europe
different ketogenic formulae
Société des Produits Nestlé (SPN)
Healthy Men and Women
12/23
12/24
GAP, NCT06593769: Glycemic and Appetite Effects of a Pre-meal Whey-Protein Microgel

Completed
N/A
18
Europe
whey-protein microgel, Placebo
Société des Produits Nestlé (SPN)
Glucose Metabolism, Appetite Regulation
12/24
12/24
Vuilleumier, Aurélie
NCT03763604: Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer

Approved for marketing
N/A
Europe, Canada, RoW
Abemaciclib, LY2835219
Eli Lilly and Company
Metastatic Breast Cancer
 
 
Bonnabry, Pascal
EDUC-IC, NCT05751772: Improving Knowledge in Heart Failure Inpatient With Therapeutic Education

Terminated
N/A
38
Europe
Patient therapeutic education, inpatient therapeutic education interview and outpatient pharmaceutical follow-up
University Hospital, Geneva, Vifor Pharma, Labatec Pharma SA, Bayer, AstraZeneca
Heart Failure With Reduced Ejection Fraction, Heart Failure; With Decompensation, Pharmacist-Patient Relations, Medication Adherence, Knowledge, Attitudes, Practice
01/24
01/24
Jermini, Mégane
EDUC-IC, NCT05751772: Improving Knowledge in Heart Failure Inpatient With Therapeutic Education

Terminated
N/A
38
Europe
Patient therapeutic education, inpatient therapeutic education interview and outpatient pharmaceutical follow-up
University Hospital, Geneva, Vifor Pharma, Labatec Pharma SA, Bayer, AstraZeneca
Heart Failure With Reduced Ejection Fraction, Heart Failure; With Decompensation, Pharmacist-Patient Relations, Medication Adherence, Knowledge, Attitudes, Practice
01/24
01/24
Luterbacher, Fanny FL Iafrate
No trials found
Stefano, Pia De
No trials found
Ronchi, Roberta
No trials found
Durham, André Durham
No trials found

Download Options